Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04701931 · ClinicalTrials.gov registry record
OCT Angiography Software Evaluation Study
A clinical trial of Retina Condition Followed by Fluorescein Angiography Imaging, sponsored by Topcon Corporation.
- Completed
- Registry status
- 135
- Enrollment target
- 2
- Study locations
NCT04701931: Completed study of Retina Condition Followed by Fluorescein Angiography Imaging, sponsored by Topcon Corporation.
NCT04701931 is a study of Retina Condition Followed by Fluorescein Angiography Imaging that has completed, run by Topcon Corporation. The registered enrollment target is 135 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04701931, a study of Retina Condition Followed by Fluorescein Angiography Imaging, has completed, sponsored by Topcon Corporation.
- COMPLETED
- Registry status
- 135 participants
- Enrollment target
- 2
- Study locations
Study Summary
Comparisons for vascular structure visualization in the retina and choroid.
Primary Outcome
The OCTA image quality comparison between Maestro2 and Cirrus
Conditions Studied
Interventions
- DEVICE Maestro2 OCTA
- DEVICE Cirrus HD-OCT 5000
- DEVICE TRC-50DX
Study Locations (2)
California
- Orange County Retina Medical Group - Santa Ana
Georgia
- Southeast Retina Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2021-01-07 |
| Est. Completion | 2023-06-06 |
What the finished NCT04701931 record still lists
NCT04701931 is an observational study that tracks outcomes without assigning an intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Retina Condition Followed by Fluorescein Angiography Imaging appearing as the primary indexed condition, and to 3 interventions - of which Maestro2 OCTA is the first listed.
NCT04701931 reports a single indexed study location in California, Georgia.
Frequently Asked Questions
What is clinical trial NCT04701931 about?
NCT04701931 is a clinical study titled "OCT Angiography Software Evaluation Study". Comparisons for vascular structure visualization in the retina and choroid.
What is the current status of trial NCT04701931?
This trial is currently completed. The enrollment target is 135 participants. The study started on 2021-01-07. Estimated completion is 2023-06-06.
What conditions does trial NCT04701931 study?
This clinical trial studies the following conditions: Retina Condition Followed by Fluorescein Angiography Imaging.
What interventions are being tested in trial NCT04701931?
The interventions under investigation include: Maestro2 OCTA (DEVICE), Cirrus HD-OCT 5000 (DEVICE), TRC-50DX (DEVICE).
Who is sponsoring clinical trial NCT04701931?
This trial is sponsored by Topcon Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04701931 being conducted?
This trial has 2 study locations across California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI